SCHEMBL9433191

SCHEMBL9433191

O=c1[nH]cccc1NCc1nc2ccccc2o1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.46
NPC1 O15118 6/20 0.46
MAPT P10636 3/20 0.46
TP53 P04637 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
LMNA P02545 1/20 0.43
LOXL2 Q9Y4K0 1/20 0.42
IDH1 O75874 1/20 0.41
HTT P42858 1/20 0.38
GFER P55789 1/20 0.38
ELANE P08246 1/20 0.38
PIK3CD O00329 1/20 0.36
PIK3CB P42338 1/20 0.36
USP2 O75604 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
GBA1 P04062 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28671248 0.76 NPC1 (0.53) RAB9ANPC1MAPTTP53SMN1; SMN2
SCHEMBL9281450 0.73 RAB9A (0.41) RAB9ANPC1MAPTTP53SMN1; SMN2
SCHEMBL6902568 0.72 NPC1 (0.63) RAB9ANPC1MAPTTP53SMN1; SMN2
SCHEMBL9431965 0.72 RAB9A (0.40) RAB9ANPC1MAPTTP53SMN1; SMN2
SCHEMBL6008059 0.71 MAPT (0.58) RAB9ANPC1MAPTTP53SMN1; SMN2
SCHEMBL9682726 0.71 RAB9A (0.39) RAB9ANPC1MAPTTP53SMN1; SMN2
SCHEMBL9681875 0.70 MAPT (0.37) RAB9ANPC1MAPTTP53SMN1; SMN2
SCHEMBL9432441 0.70 RAB9A (0.43) RAB9ANPC1MAPTTP53SMN1; SMN2
SCHEMBL2736597 0.69 CNR2 (0.45) RAB9ANPC1MAPTTP53SMN1; SMN2
SCHEMBL6981618 0.69 NPC1 (0.54) RAB9ANPC1MAPTTP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5308854-A 2-benzoxazolylalkyl substituted pyridin-2(1H)(thi)ones; AIDS MERCK & CO., INC. (US) 1994-05-03 US disclosed
EP-0484071-A2 Synergism of HIV reverse transcriptase inhibitors MERCK & CO. INC. (US) 1992-05-06 EP disclosed
EP-0462800-A2 Inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1991-12-27 EP disclosed